MOBILion Systems, Inc.

MOBILion Systems, Inc. MOBILion’s technology makes it easy to separate, identify & analyze the most challenging molecules that other instruments fail to detect.

We make today’s treatment’s safer, more effective & empower tomorrow’s disease prediction & diagnosis

Mass spectrometry and proteomics are entering a new era. Our Chief Technology Officer Daniel DeBord, PhD shared with Tec...
12/27/2024

Mass spectrometry and proteomics are entering a new era. Our Chief Technology Officer Daniel DeBord, PhD shared with Technology Networks how MOBILion's PAMAF operation mode fills a critical gap in proteomics research by providing unprecedented sensitivity and speed in biomolecule analysis. Learn how the PAMAF operation mode uses high-resolution ion mobility (HRIM) instead of a quadrupole filter to eliminate the tradeoff between speed and sensitivity encountered in traditional MS/MS analysis and serves to significantly reduce the number of chimeric spectra generated by separating isomeric and isobaric ions in the mobility dimension before fragmentation. For proteomics, lipidomics, metabolomics, and personalized medicine - discover how this innovation could transform drug discovery and clinical research with unprecedented speed, sensitivity and depth of characterization.
Read the full interview: https://www.technologynetworks.com/analysis/blog/revolutionizing-biomolecule-analysis-with-advanced-mass-spectrometry-393940

As we celebrate this holiday season, we're grateful for our incredible community of scientists, partners, and customers ...
12/23/2024

As we celebrate this holiday season, we're grateful for our incredible community of scientists, partners, and customers who share our passion for revealing what others leave unseen. Your innovative spirit drives us to keep pushing boundaries - from our revolutionary MOBIE system to our groundbreaking PAMAF technology for . Warmest wishes from all of us at MOBILion!

Struggling to separate and identify epimers? Our MOBIE System achieves what traditional methods can't. In just 2 minutes...
12/19/2024

Struggling to separate and identify epimers? Our MOBIE System achieves what traditional methods can't. In just 2 minutes, we can separate epimeric pairs of green tea catechins - offering deeper insights into the composition of green tea extracts and their potential health benefits.

From nutritional analysis to quality control, MOBIE delivers unprecedented confidence in compound identification for food science applications with superior reproducibility. Download our application note to learn how MOBIE can help you revolutionize your food science analysis: https://www.mobilionsystems.com/resources/pushing-the-limits-of-high-resolution-ion-mobility-hrim-for-catechin-epimer-analysis

Exciting news from MOBILion! We’re thrilled to announce our latest partnership with Dr. Oliver Schmitz and his team at t...
12/18/2024

Exciting news from MOBILion! We’re thrilled to announce our latest partnership with Dr. Oliver Schmitz and his team at the University of Duisburg-Essen, a recognized leader in advancing analytical chemistry for complex sample analysis. Dr. Schmitz specializes in the analysis of complex samples, optimization of multidimensional LC and GC, and cutting-edge ion mobility-mass spectrometry—making him the perfect partner to showcase the potential of our technology.

This partnership integrates the newest version of MOBILion's product into his research, designed specifically for low mass applications like discovery metabolomics. It’s a significant step forward, showcasing the flexibility of our SLIM technology to accelerate research across the multiomics spectrum, from metabolomics to proteomics and beyond.

With this limited-release product and our rapidly advancing proteomics efforts, MOBILion continues to advance next-generation separation science, empowering researchers to uncover insights faster and with greater accuracy and precision.

Together, we’re advancing the frontiers of science! Reach out to info@mobilionsystems.com to be part of this exciting journey!

https://www.prnewswire.com/news-releases/mobilion-systems-partners-with-leading-researcher-at-university-of-duisburg-essen-to-advance-metabolomics-research-and-discovery-302334492.html

We are advancing the future of separation science through continuous innovation. By evolving and commercializing breakth...
12/13/2024

We are advancing the future of separation science through continuous innovation. By evolving and commercializing breakthrough SLIM technology, we're delivering products that fundamentally push the boundaries of what today’s LC-MS workflows can do.

Click here to learn how we're reshaping the paradigm of separation science and analytical characterization in Daniel DeBord's discussion with Separation Science: https://hubs.ly/Q02_FT920

Our new approach, PAMAF, enhances specificity in proteomics research and enables more accurate separation of these 'know...
12/12/2024

Our new approach, PAMAF, enhances specificity in proteomics research and enables more accurate separation of these 'known unknowns' and deeper insights into complex biological systems.

Discover how this breakthrough technology can elevate your proteomics research: https://hubs.ly/Q02_rKg10

Thank you to our exceptional team for joining us at MOBILion's annual Thanksgiving lunch today! We appreciate your conti...
11/27/2024

Thank you to our exceptional team for joining us at MOBILion's annual Thanksgiving lunch today! We appreciate your continuous dedication to advancing analytical science throughout the year.

Did you know that traditional MS/MS systems use as little as 0.5% of available ion signal? Our groundbreaking Parallel A...
11/26/2024

Did you know that traditional MS/MS systems use as little as 0.5% of available ion signal? Our groundbreaking Parallel Accumulation with Mobility Aligned Fragmentation (PAMAF) method achieves near 100% ion utilization efficiency, offering an order of magnitude improvement in sensitivity. This leap forward allows for the detection of analytes at lower concentrations, providing deeper insights into complex samples.

Learn how this enhanced sensitivity could revolutionize your research: https://hubs.ly/Q02Zlnb90

How are labs adapting to rising   concerns?Our SVP of Global Business, Frederick Strathmann, Ph.D., joins experts from t...
11/25/2024

How are labs adapting to rising concerns?

Our SVP of Global Business, Frederick Strathmann, Ph.D., joins experts from the EPA, Million Marker, Eurofins, and NMS Labs in Clinical Chemistry to discuss the critical questions surrounding PFAS testing and analysis.

From regulatory compliance to patient care, discover how advanced analytical technologies are transforming our ability to detect, quantify, and understand these persistent compounds. These experts explore why traditional testing methods fall short and how innovations in laboratory medicine are helping protect public health.

Find the article in Clinical Chemistry here: https://hubs.ly/Q02Zlknb0

Did you know thousands of PFAS compounds exist, but traditional testing methods detect only a fraction?Hear from experts...
11/21/2024

Did you know thousands of PFAS compounds exist, but traditional testing methods detect only a fraction?

Hear from experts from the EPA, Million Marker, Eurofins, and NMS Labs as they explore how next-generation analytical technologies are revolutionizing our approach to PFAS detection and monitoring in a new Clinical Chemistry Q&A article.

Learn how these advances are helping laboratories deliver more comprehensive PFAS analyses: https://hubs.ly/Q02YTJbn0

11/20/2024

We’re honored to welcome Steven Carr, Ashok Dongre, Alexey Nesvizhskii, Benjamin Orsburn, Birgit Schilling, Nikolai Slavov, and John Yates as members of our inaugural Proteomics Advisory Board! Following our successful kickoff meeting, we're already advancing plans to experimentally validate our breakthrough PAMAF technology.

These six distinguished leaders bring decades of pioneering expertise in mass spectrometry, bioinformatics, and protein analysis, with more than 1,500 peer-reviewed publications collectively.

Together, we're making rapid progress toward realizing PAMAF's potential across critical applications - from advancing single-cell proteomics to enhancing biomarker discovery.

This marks an exciting chapter in our mission to reveal what others leave unseen.

Learn more: https://hubs.ly/Q02Y_75l0

Our CEO Melissa Sherman spoke with GenomeWeb about how our new PAMAF approach can transform   research. By removing the ...
11/19/2024

Our CEO Melissa Sherman spoke with GenomeWeb about how our new PAMAF approach can transform research. By removing the quadrupole, this technology could allow scientists to conduct mass spec-based proteomics with improved speed and sensitivity.

Learn more about our approach and how it’s a paradigm shift for proteomics and beyond: https://hubs.ly/Q02YKZb_0

Address

4 Hillman Drive
Chadds Ford, PA
19317

Alerts

Be the first to know and let us send you an email when MOBILion Systems, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MOBILion Systems, Inc.:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram